GeneFerm Biotechnology Co Ltd Total Liabilities

Latest as of June 2025: NT$453.10 Million TWD ≈ $14.28 Million USD

GeneFerm Biotechnology Co Ltd total liabilities. Based on the latest financial reports, GeneFerm Biotechnology Co Ltd (1796) has total liabilities worth NT$453.10 Million TWD (≈ $14.28 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check GeneFerm Biotechnology Co Ltd liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Total Liabilities of GeneFerm Biotechnology Co Ltd (2017–2024)

Total liabilities of GeneFerm Biotechnology Co Ltd from 2017 to 2024. This chart illustrates how GeneFerm Biotechnology Co Ltd's total liabilities have evolved over time, based on quarterly financial data.

GeneFerm Biotechnology Co Ltd Competitors by Total Liabilities

The table below lists competitors of GeneFerm Biotechnology Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Royalindo Investa Wijaya JK:INDO	Indonesia	Rp6.47 Billion
FORTEC Elektronik AG F:FEV	Germany	€18.79 Million
HPQ Silicon Resources Inc V:HPQ	Canada	CA$3.31 Million
Accentis BR:ACCB	Belgium	€18.28 Million
01 Communique Laboratory Inc V:ONE	Canada	CA$333.45K
JASTECH Ltd KQ:090470	Korea	₩121.47 Billion
Edip Gayrimenkul Yatirim Sanayi ve Ticaret AS IS:EDIP	Turkey	TL1.37 Billion
Yirendai Ltd NYSE:YRD	USA	$5.11 Billion

Liability Composition Analysis (2017–2024)

This chart breaks down GeneFerm Biotechnology Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see balance sheet size of GeneFerm Biotechnology Co Ltd.

Liquidity & Leverage Metrics

GeneFerm Biotechnology Co Ltd Total Liabilities Ratios Explained

GeneFerm Biotechnology Co Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	4.03	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.57	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.36	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how GeneFerm Biotechnology Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for GeneFerm Biotechnology Co Ltd (2017–2024)

The table below shows the annual total liabilities of GeneFerm Biotechnology Co Ltd from 2017 to 2024.

Year	Total Liabilities	Change
2024-12-31	NT$358.31 Million ≈ $11.29 Million	+26.82%
2023-12-31	NT$282.54 Million ≈ $8.90 Million	-21.27%
2022-12-31	NT$358.86 Million ≈ $11.31 Million	-36.96%
2021-12-31	NT$569.22 Million ≈ $17.93 Million	-2.93%
2020-12-31	NT$586.38 Million ≈ $18.47 Million	+1174.74%
2019-12-31	NT$46.00 Million ≈ $1.45 Million	-67.30%
2018-12-31	NT$140.69 Million ≈ $4.43 Million	-27.40%
2017-12-31	NT$193.79 Million ≈ $6.11 Million	--

About GeneFerm Biotechnology Co Ltd

TWO:1796 Taiwan Drug Manufacturers - Specialty & Generic

Market Cap

$34.09 Million

NT$1.08 Billion TWD

Market Cap Rank

#23109 Global

#1445 in Taiwan

Share Price

NT$26.10

Change (1 day)

-1.69%

52-Week Range

NT$26.10 - NT$50.60

All Time High

NT$149.87